Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack

NCT02122718 is registered in ClinicalTrials.gov with NHS Greater Glasgow and Clyde as lead sponsor.

NCT NCT02122718
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02122718 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Xanthine Oxidase Inhibition for Improvement of Long-term Outcomes Following Ischaemic Stroke and Transient Ischaemic Attack
Lead sponsor
NHS Greater Glasgow and Clyde
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2014
Completion date
February 28, 2021
Enrollment
464 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

ischaemic stroke